Jeffrey LaRose, Chief Scientific Officer at HeartWare International, Inc. (HTWR), sold 1,221 shares at $47.55 ($57K) on 2015-12-22, disclosed to the SEC on 2015-12-23.
Scheduled sale ($57k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $46.29 | 1,121 | $52K | 91.6% |
| 2 | $47.55 | 100 | $5K | 8.4% |
| Total | $46.39 avg | 1,221 | $57K | 100% |
| Filing → |
| HTWR | SELL | 2016-02-09 | $20K | — | Filing → |
| HTWR | SELL | 2015-02-26 | $30K | — | Filing → |
| HTWR | SELL | 2015-02-10 | $42K | — | Filing → |